Seeking AlphaCodex · 实盘不做把握 2/10
北京时间·🕒 发布 08-03 23:13:03时区推断·⟳ 抓取 08-03 23:13:11·⚡ 决策 08-04 11:15:35 +12h02m·84.6 天前
Rhythm Pharmaceuticals将于8月4日盘前公布Q2业绩，市场预期EPS为-0.83美元、收入6766万美元
这只是财报前一致预期与修正次数汇总，未披露实际收入、亏损或指引变化。
📄 原文Seeking Alpha↗ 原文
Rhythm Pharmaceuticals Q2 2026 Earnings Preview
- Rhythm Pharmaceuticals (RYTM) is scheduled to announce Q2 earnings results on Tuesday, August 4th, before market open…
不做 Rhythm Pharmaceuticals（RYTM.US）
仅为盘前财报预告与一致预期，缺少实际业绩或指引 surprise，不做。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-08-03 · 扩散 medium · price-in 风险 high ↗
关键理由
- 这只是财报前一致预期与修正次数汇总，未披露实际收入、亏损或指引变化。
主要风险
- 正式业绩或Imcivree等产品销售数据若显著偏离预期，需由新信号重新判断。
原文全文
展开原文 · 473 字
- Rhythm Pharmaceuticals (RYTM) is scheduled to announce Q2 earnings results on Tuesday, August 4th, before market open.
- The consensus EPS Estimate is -$0.83 and the consensus Revenue Estimate is $67.66M
- Over the last 1 year, RYTM has beaten EPS estimates 75% of the time and has beaten revenue estimates 50% of the time.
- Over the last 3 months, EPS estimates have seen 3 upward revisions and 6 downward. Revenue estimates have seen 8 upward revisions and 3 downward.
- The consensus EPS Estimate is -$0.83 and the consensus Revenue Estimate is $67.66M
- Over the last 1 year, RYTM has beaten EPS estimates 75% of the time and has beaten revenue estimates 50% of the time.
- Over the last 3 months, EPS estimates have seen 3 upward revisions and 6 downward. Revenue estimates have seen 8 upward revisions and 3 downward.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。